GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (FRA:NZM2) » Definitions » Cyclically Adjusted PS Ratio

Novonesis AS (FRA:NZM2) Cyclically Adjusted PS Ratio : 7.36 (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Novonesis AS Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Novonesis AS's current share price is €56.26. Novonesis AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €7.64. Novonesis AS's Cyclically Adjusted PS Ratio for today is 7.36.

The historical rank and industry rank for Novonesis AS's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:NZM2' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.01   Med: 7.84   Max: 11.43
Current: 7.45

During the past years, Novonesis AS's highest Cyclically Adjusted PS Ratio was 11.43. The lowest was 5.01. And the median was 7.84.

FRA:NZM2's Cyclically Adjusted PS Ratio is ranked worse than
93.88% of 1209 companies
in the Chemicals industry
Industry Median: 1.21 vs FRA:NZM2: 7.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Novonesis AS's adjusted revenue per share data for the three months ended in Dec. 2023 was €2.218. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €7.64 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis AS Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Novonesis AS's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Cyclically Adjusted PS Ratio Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.61 7.82 11.24 6.49 6.55

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 6.32 5.73 5.04 6.55

Competitive Comparison of Novonesis AS's Cyclically Adjusted PS Ratio

For the Specialty Chemicals subindustry, Novonesis AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Cyclically Adjusted PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Cyclically Adjusted PS Ratio falls into.



Novonesis AS Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Novonesis AS's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=56.26/7.64
=7.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Novonesis AS's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.218/116.7000*116.7000
=2.218

Current CPI (Dec. 2023) = 116.7000.

Novonesis AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.278 99.600 1.497
201406 1.298 99.700 1.519
201409 1.362 99.700 1.594
201412 1.371 99.400 1.610
201503 1.542 100.200 1.796
201506 1.489 100.300 1.732
201509 1.529 100.200 1.781
201512 1.505 99.800 1.760
201603 1.581 100.200 1.841
201606 1.514 100.600 1.756
201609 1.505 100.200 1.753
201612 1.666 100.300 1.938
201703 1.681 101.200 1.938
201706 1.596 101.200 1.840
201709 1.623 101.800 1.861
201712 1.671 101.300 1.925
201803 1.603 101.700 1.839
201806 1.602 102.300 1.828
201809 1.680 102.400 1.915
201812 1.717 102.100 1.963
201903 1.615 102.900 1.832
201906 1.606 102.900 1.821
201909 1.737 102.900 1.970
201912 1.762 102.900 1.998
202003 1.787 103.300 2.019
202006 1.590 103.200 1.798
202009 1.639 103.500 1.848
202012 1.649 103.400 1.861
202103 1.807 104.300 2.022
202106 1.715 105.000 1.906
202109 1.808 105.800 1.994
202112 1.843 106.600 2.018
202203 2.103 109.900 2.233
202206 2.061 113.600 2.117
202209 2.108 116.400 2.113
202212 2.190 115.900 2.205
202303 2.236 117.300 2.225
202306 2.038 116.400 2.043
202309 2.152 117.400 2.139
202312 2.218 116.700 2.218

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis AS  (FRA:NZM2) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Novonesis AS Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (FRA:NZM2) Business Description

Industry
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (FRA:NZM2) Headlines

No Headlines